Share this article
Share this article
Partnership comes on the cusp of the federal budget expected to focus on health, childcare, and the shortage of women in the workforce
TORONTO, April 16, 2021 /CNW/ - Today, One Human Service Network ( OneHSN ), a Canadian-based corporation that optimizes human service delivery through its innovative digital childcare platform Childcare Connect
TM, has entered a technology partnership with BookJane, a technology platform that helps long term care (LTC) and senior living facilities find, schedule and communicate with staff. The innovative technology partnership is expected to help alleviate one of the country s most pressing issues a shortage of qualified early childhood educators.
Posted on 288
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has agreed with Worldpharma Biotech (“Worldpharma”), through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”), to export Good Manufacturing Processes (GMP) certified medical cannabis from Portugal to Spain. The shipment marks the first medical cannabis import into Spain by Worldpharma and the 17
th country to receive Tilray medical cannabis worldwide.
The Agencia Española de Medicamentos y Productos Sanitorios (AEMPS), Spain’s food and drug administration, has approved Worldpharma to import Tilray’s GMP-certified medical cannabis as raw material from its Portugal facility to Spain. With Tilray’s pharmaceutical-grade cannabis, Worldpharma will develop medical cannabis products for clinical trials in Spanish Hospitals for diseases suc
Tilray, Inc.: Tilray Exports First Shipment of Medical Cannabis to Spain
Tilray medical cannabis will now be available in 17 countries around the world
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has agreed with Worldpharma Biotech ( Worldpharma ), through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. ( Tilray Portugal ), to export Good Manufacturing Processes (GMP) certified medical cannabis from Portugal to Spain. The shipment marks the first medical cannabis import into Spain by Worldpharma and the 17
th country to receive Tilray medical cannabis worldwide.
The Agencia Española de Medicamentos y Productos Sanitorios (AEMPS), Spain s food and drug administration, has approved Worldpharma to import Tilray s GMP-certified medical cannabis as raw material from its Portugal facility to Spain. With Tilray s pharmaceutical-grade cannabis, Worldpharma will develop medical cannabis pro
Tilray, Inc.: Tilray Receives the First and Only Market Authorization to Offer Medical Cannabis Products in Portugal
Portugal will become the 16
th country where patients can access Tilray medical cannabis products
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that it has received the necessary approvals and market authorization in accordance with the Portuguese legislation to offer Tilray medical cannabis products in Portugal from its GMP-certified EU facility in Cantanhede, Portugal. The market authorization was issued by Infarmed, the Portuguese National Authority of Medicines and Health Products, whose rigorous process in providing such consent is internationally recognized.
Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France
Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced that it has been selected by the French National Agency for the Safety of Medicines and Health Products (ANSM) to supply Good Manufacturing Processes (GMP) certified medical cannabis products for experimentation in France. Tilray will supply GMP-produced medical cannabis products to serve patients in need for the duration of the French experiment (18-24 months), due to begin in the first quarter of 2021.